Zeta Diagnostics has developed a patent-pending device that provides long-term objective measurement of middle ear pressure regulation, allowing ear specialists to collect data while patients engage in everyday activities like listening to music or watching TV. This technology addresses the challenge of diagnosing eustachian tube dysfunction, which is responsible for 80% of consultations with ear specialists and can lead to serious conditions such as cholesteatoma and hearing loss.
Funding
$530K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Diagnosing eustachian tube dysfunction (ETD), which accounts for a significant portion of ear specialist consultations, is challenging due to the lack of objective, long-term measurement tools for middle ear pressure regulation. The inability to accurately assess ETD can lead to serious complications, including cholesteatoma and hearing loss.
Solution
Zeta Diagnostics offers a novel, patent-pending device that enables long-term, objective monitoring of middle ear pressure regulation in patients. This technology allows ear specialists to gather comprehensive data on a patient's ability to regulate middle ear pressure during everyday activities. By quantifying middle ear pressure regulation over extended periods, the device facilitates more confident and accurate ETD diagnoses. The device aims to improve diagnostic accuracy, potentially preventing the progression to more severe middle ear health problems.
Target Audience
The primary users are ear specialists seeking improved diagnostic tools for eustachian tube dysfunction.
Features
- Long-term, objective measurement of middle ear pressure regulation
- Data collection during normal patient activities (e.g., listening to audio)
- Identification and quantification of a patient's ability to regulate middle ear pressure over time